Cargando…
Hyperactivated mTORC1 downregulation of FOXO3a/PDGFRα/AKT cascade restrains tuberous sclerosis complex-associated tumor development
Hyperactivation of mammalian target of rapamycin complex 1 (mTORC1), caused by loss-of-function mutations in either the TSC1 or TSC2 gene, leads to the development of tuberous sclerosis complex (TSC), a benign tumor syndrome with multiple affected organs. mTORC1-mediated inhibition of AKT constrains...
Autores principales: | Wang, Li, Ni, Zhaofei, Liu, Yujie, Ji, Shuang, Jin, Fuquan, Jiang, Keguo, Ma, Junfang, Ren, Cuiping, Zhang, Hongbing, Hu, Zhongdong, Zha, Xiaojun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589626/ https://www.ncbi.nlm.nih.gov/pubmed/28903387 http://dx.doi.org/10.18632/oncotarget.18963 |
Ejemplares similares
-
mTORC1-mediated downregulation of COX2 restrains tumor growth caused by TSC2 deficiency
por: Li, Hongwu, et al.
Publicado: (2016) -
Elevated ITGA5 facilitates hyperactivated mTORC1-mediated progression of laryngeal squamous cell carcinoma via upregulation of EFNB2
por: Li, Dapeng, et al.
Publicado: (2022) -
Bi-steric mTORC1 inhibitors induce apoptotic cell death in tumor models with hyperactivated mTORC1
por: Du, Heng, et al.
Publicado: (2023) -
Hyperactivation of mTORC1 disrupts cellular homeostasis in cerebellar Purkinje cells
por: Sakai, Yusuke, et al.
Publicado: (2019) -
Hyperactivation of mTORC1 in a double hit mutant zebrafish model of tuberous sclerosis complex causes increased seizure susceptibility and neurodevelopmental abnormalities
por: De Meulemeester, Ann-Sofie, et al.
Publicado: (2022)